Mitchell Chan - Dec 1, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
Christopher R. Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
4
Date filed
12/3/2021, 07:44 PM
Next filing
Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +80K $0.00 80K Dec 1, 2021 Common Stock 80K $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in three substantially equal installments on December 1, 2022, December 1, 2023 and December 1, 2024, subject to the Reporting Person's continued service on each such vesting date.